Department of Cardiology, Maimonides Medical Center, 4802 Tenth Avenue, Brooklyn, NY 11219, USA.
Department of Internal Medicine, Maimonides Medical Center, 475 Seaview Avenue, Staten Island NY 10305, USA.
QJM. 2021 May 19;114(3):182-189. doi: 10.1093/qjmed/hcab029.
Elderly patients with COVID-19 disease are at increased risk for adverse outcomes. Current data regarding disease characteristics and outcomes in this population are limited.
To delineate the adverse factors associated with outcomes of COVID-19 patients ≥75 years of age.
Retrospective cohort study.
Patients were classified into mild/moderate, severe/very severe and critical disease (intubated) based on oxygen requirements. The primary outcome was in-hospital mortality.
A total of 355 patients aged ≥75 years hospitalized with COVID-19 between 19 March and 25 April 2020 were included.Mean age was 84.3 years. One-third of the patients developed critical disease. Mean length of stay was 7.10 days. Vasopressors were required in 27%, with the highest frequency in the critical disease group (74.1%). Overall mortality was 57.2%, with a significant difference between severity groups (mild/moderate disease: 17.4%, severe/very severe disease: 71.3%, critical disease: 94.9%, P < 0.001).Increased age, dementia, and severe/very severe and critical disease groups were independently associated with increased odds for mortality while diarrhea was associated with decreased odds for mortality (OR: 0.12, 95% CI: 0.02-0.60, P < 0.05). None of the cardiovascular comorbidities were significantly associated with mortality.
Age and dementia are associated with increased odds for mortality in patients ≥75 years of age hospitalized with COVID-19. Those who require intubation have the greatest odds for mortality. Diarrhea as a presenting symptom was associated with lower odds for mortality.
患有 COVID-19 疾病的老年患者发生不良结局的风险增加。目前关于该人群疾病特征和结局的数据有限。
明确与 COVID-19 患者(年龄≥75 岁)结局相关的不良因素。
回顾性队列研究。
根据氧需求将患者分为轻症/中症、重症/危重症和危重症(插管)。主要结局为住院期间死亡率。
2020 年 3 月 19 日至 4 月 25 日期间,共有 355 名年龄≥75 岁的 COVID-19 住院患者纳入研究。患者平均年龄为 84.3 岁。三分之一的患者发生危重症。平均住院时间为 7.10 天。27%的患者需要使用升压药,危重症组的使用频率最高(74.1%)。总体死亡率为 57.2%,严重程度组之间存在显著差异(轻症/中症:17.4%,重症/危重症:71.3%,危重症:94.9%,P<0.001)。高龄、痴呆和重症/危重症及危重症组与死亡率增加独立相关,而腹泻与死亡率降低相关(OR:0.12,95%CI:0.02-0.60,P<0.05)。无心血管合并症与死亡率显著相关。
年龄和痴呆与 COVID-19 住院患者(年龄≥75 岁)死亡率增加相关。需要插管的患者死亡率最高。以腹泻为首发症状与死亡率降低相关。